IP Verse

Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase - EP2399588

The patent EP2399588 was granted to Ionis Pharmaceuticals on Apr 29, 2020. The application was originally filed on Jan 18, 2002 under application number EP11178613A. The patent is currently recorded with a legal status of "Revoked".

EP2399588

IONIS PHARMACEUTICALS
Application Number
EP11178613A
Filing Date
Jan 18, 2002
Status
Revoked
Nov 18, 2022
Grant Date
Apr 29, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GILEAD SCIENCESJan 7, 2021J A KEMPADMISSIBLE

Patent Citations (40) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONDE408366
DESCRIPTIONEP0043722
DESCRIPTIONEP0866070
DESCRIPTIONGB2337262
DESCRIPTIONUS3480613
DESCRIPTIONUS3654262
DESCRIPTIONUS4439604
DESCRIPTIONUS5413999
DESCRIPTIONUS5770725
DESCRIPTIONUS5849905
DESCRIPTIONUS5922695
DESCRIPTIONUS5977089
DESCRIPTIONUS6020482
DESCRIPTIONUS6043230
DESCRIPTIONUS6069249
DESCRIPTIONWO0009543
DESCRIPTIONWO0025780
DESCRIPTIONWO0059929
DESCRIPTIONWO0100622
DESCRIPTIONWO0160379
DESCRIPTIONWO0174768
DESCRIPTIONWO0181325
DESCRIPTIONWO9741211
DESCRIPTIONWO9817679
DESCRIPTIONWO9822496
DESCRIPTIONWO9846630
DESCRIPTIONWO9907733
DESCRIPTIONWO9907734
DESCRIPTIONWO9938888
DESCRIPTIONWO9950230
DESCRIPTIONWO9964442
OPPOSITIONUS6063628
OPPOSITIONUS7964580
OPPOSITIONWO0190121
OPPOSITIONWO9312132
OPPOSITIONWO9943691
SEARCHUS6063628
SEARCHWO0190121
SEARCHWO9312132
SEARCHWO9943691

Non-Patent Literature (NPL) Citations (104) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- A.C. ALLISON, E.M. EUGUI, AGENTS ACTION, (1993), vol. 44, page 165-
DESCRIPTION- ACTA CRYSTALLOGR., SECT. C: CRYST. STRUCT. COMMUN., (1987), vol. C43, page 1790-
DESCRIPTION- ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, (1997), vol. 8, page 557-
DESCRIPTION- B. DYMOCK ET AL., "Novel approaches to the treatment of hepatitis C virus infection", ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, (2000), vol. 11, pages 79 - 96-
DESCRIPTION- BEIGELMAN ET AL., CARBOHYD. RES., (1987), vol. 166, pages 219 - 232-
DESCRIPTION- BIOCHEMISTRY, (1994), vol. 33, page 2703-
DESCRIPTION- B.W. DYMOCK, "Emerging therapies for hepatitis C virus infection", EMERGING DRUGS, (2001), vol. 6, pages 13 - 42-
DESCRIPTION- CAN. J CHEM., (1977), vol. 55, page 1251-
DESCRIPTION- C. CRABB, "Hard-Won Advances Spark Excitement about Hepatitis C", SCIENCE, (2001), pages 506 - 507-
DESCRIPTION- Chemistry ofNucleosides and Nucleotides, PLENUM PRESS, (1988), vol. 1-3-
DESCRIPTION- CHEM. PHARM. BULL., (1968), vol. 16, page 1616-
DESCRIPTION- CHEM. PHARM. BULL., (1981), vol. 29, page 1034-
DESCRIPTION- CHEM. PHARM. BULL., (1982), vol. 30, page 2223-
DESCRIPTION- CHEM. PHARM. BULL., (1987), vol. 35, page 2605-
DESCRIPTION- CHEM. PHARM. BULL., (1993), vol. 41, page 775-
DESCRIPTION- CHEM. REV., (2000), vol. 100, page 2047-
DESCRIPTION- CORY, A. H. ET AL., "Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture", CANCER COMMUN., (1991), vol. 3, page 207, XP009009200-
DESCRIPTION- C.R. WAGNER, V.V. IYER, E.J. MCINTEE, "Pronucleotides: Toward the In Vivo Delivery of Antiviral and Anticancer Nucleotides", MED. RES. REV, (2000), vol. 20, pages 1 - 35-
DESCRIPTION- C.R. WAGNER, V.V. IYER, E.J. MCINTEE, "Pronucleotides: Toward the In Vivo Delivery of Antiviral and Anticancer Nucleotides", MED. RES. REV., (2000), vol. 20, pages 1 - 35-
DESCRIPTION- D. MORADPOUR ET AL., "Current and evolving therapies for hepatitis C", EUROPEAN J. GASTROENTEROL. HEPATOL., (1999), vol. 11, pages 1189 - 1202-
DESCRIPTION- FEBSLETT., (1989), vol. 250, page 139-
DESCRIPTION- G.M. LAUER, B.D. WALKER, "Hepatitis C Virus Infection", N. ENGL. J. MED., (2001), vol. 345, pages 41 - 52, XP009189178-
DESCRIPTION- HELV. CHIM. ACTA, (1990), vol. 73, page 1879-
DESCRIPTION- HELV. CHIM. ACTA, (1995), vol. 78, page 486-
DESCRIPTION- HELV. CHIM. ACTA, (1999), vol. 82, page 2052-
DESCRIPTION- HETEROCYCLES, (1993), vol. 35, page 825-
DESCRIPTION- H. NAKABAYASHI ET AL., CANCER RES., (1982), vol. 42, page 3858-
DESCRIPTION- J ACQUIRED IMMUNE DEFIC. SYNDR., (2000), vol. 23, page 227-
DESCRIPTION- J AM. CHEM. SOC., (1975), vol. 97, page 2916-
DESCRIPTION- J AM. CHEM. SOC., (1976), vol. 98, page 1492-
DESCRIPTION- J. AM. CHEM. SOC., (1976), vol. 98, page 7870-
DESCRIPTION- J. AM. CHEM. SOC., (1983), vol. 105, page 4059-
DESCRIPTION- J AM. CHEM. SOC., (1984), vol. 106, page 6379-
DESCRIPTION- J. CHEM. SOC., (1960), page 131-
DESCRIPTION- J CHEM. SOC. PERKIN TRANS., (1989), vol. 1, page 2375-
DESCRIPTION- J. CHEM. SOC. PERKIN TRANS., (1989), vol. 1, page 2375-
DESCRIPTION- J. KIRSCHBAUM, ANAL. PROFILES DRUG SUBS., (1983), vol. 12, pages 1 - 36-
DESCRIPTION- J MED CHEM., (1975), vol. 18, page 721-
DESCRIPTION- J. MED CHEM., (1976), vol. 19, page 1265-
DESCRIPTION- J. MED. CHEM., (1976), vol. 19, page 1265-
DESCRIPTION- J MED CHEM., (1983), vol. 26, page 25-
DESCRIPTION- J MED CHEM., (1983), vol. 26, page 286-
DESCRIPTION- J MED CHEM., (1987), vol. 30, page 481-
DESCRIPTION- J. MED. CHEM., (1990), vol. 33, page 1984-
DESCRIPTION- J MED CHEM., (1991), vol. 34, page 2195-
DESCRIPTION- J MED. CHEM., (1991), vol. 34, page 2195-
DESCRIPTION- J. MED CHEM., (1991), vol. 34, page 2195-
DESCRIPTION- J. MED. CHEM., (1992), vol. 35, page 2283-
DESCRIPTION- JMED. CHEM., (1993), vol. 36, page 353-
DESCRIPTION- J MED CHEM., (1995), vol. 38, page 3957-
DESCRIPTION- J. MED CHEM., (1995), vol. 38, page 3957-
DESCRIPTION- J MED. CHEM., (1996), vol. 39, page 1771-
DESCRIPTION- J. MED. CHEM., (1998), vol. 41, page 1708-
DESCRIPTION- JMED. CHEM., (1998), vol. 41, page 1708-
DESCRIPTION- J ORG. CHEM., (1963), vol. 28, page 3041-
DESCRIPTION- J ORG. CHEM., (1974), vol. 39, page 1891-
DESCRIPTION- JORG.CHEM., (1978), vol. 43, page 2536-
DESCRIPTION- J ORG. CHEM., (1982), vol. 47, page 226-
DESCRIPTION- J ORG. CHEM., (1996), vol. 61, page 781-
DESCRIPTION- J.O. SAUNDERS, S.A. RAYBUCK, "Inosine Monophosphate Dehydrogenase: Consideration of Structure, Kinetics, and Therapeutic Potential", ANN. REP. MED. CHEM., (2000), vol. 35, pages 201 - 210-
DESCRIPTION- J.P.VACCA ET AL., PROC. NATL. ACAD. SCI., (1994), vol. 91, pages 4096 - 4100-
DESCRIPTION- LIEBIGS, ANN. CHEM., (1983), vol. 1, page 137-
DESCRIPTION- LIEBIGS ANN. CHEM., (1984), pages 708 - 721-
DESCRIPTION- LIEBIGS ANN. CHEM., (1984), vol. 4, page 708-
DESCRIPTION- "Microtiter Assay for Interferon: Microspectrophotometric Quantitation of Cytopathic Effect", APPL. ENVIRON. MICROBIOL., (1976), vol. 31, pages 35 - 38-
DESCRIPTION- M. IKEHARA, S. YAMADA, CHEM. PHARM. BULL., (1971), vol. 19, page 104-
DESCRIPTION- M. S. WOLFE ET AL., TETRAHEDRON LETT., (1995), vol. 36, pages 7611 - 7614-
DESCRIPTION- Nucleic Acid Chemistry, WILEY-INTERSCIENCE, (1991), pages 16 - 17-
DESCRIPTION- NUCLEIC ACIDS RES., (1983), vol. 11, pages 871 - 872-
DESCRIPTION- NUCLEOSIDES NUCLEOTIDES, (1991), vol. 10, page 719-
DESCRIPTION- NUCLEOSIDES NUCLEOTIDES, (1992), vol. 11, page 787-
DESCRIPTION- NUCLEOSIDES NUCLEOTIDES, (1994), vol. 13, page 1049-
DESCRIPTION- NUCLEOSIDES NUCLEOTIDES, (1994), vol. 13, page 1425-
DESCRIPTION- NUCLEOSIDES, NUCLEOTIDES, NUCLEIC ACIDS, (2000), vol. 19, page 1123-
DESCRIPTION- R. E. HARRY-O'KURU ET AL., J. ORG. CHEM., (1997), vol. 62, pages 1754 - 1759-
DESCRIPTION- SEELA ET AL., J ORG. CHEM., (1982), vol. 47, page 226-
DESCRIPTION- SYNTHESIS, (1994), page 1163-
DESCRIPTION- SYNTHESIS, (1998), page 1327-
DESCRIPTION- SYNTHETIC COMMUN., (1998), vol. 28, page 3835-
DESCRIPTION- TETRAHEDRON LETT., (1967), vol. 50, page 5065-
DESCRIPTION- TETRAHEDRON. LETT., (1983), vol. 25, page 4793-
DESCRIPTION- TETRAHEDRON LETT., (1986), vol. 27, page 1011-
DESCRIPTION- TETRAHEDRON LETT., (1987), vol. 28, page 5107-
DESCRIPTION- TETRAHEDRON LETT., (1989), vol. 30, page 2329-
DESCRIPTION- "Use of disposable microtissue culture plates for antiviral and interferon induction studies", APPL. MICROBIOL., (1971), vol. 22, pages 797 - 801-
DESCRIPTION- V. LOHMANN, F. KORNER, J-O. KOCH, U. HERIAN, L. THEILMANN, R. BARTENSCHLAGER, "Replication of a Sub-genomic Hepatitis C Virus RNAs in a Hepatoma Cell Line", SCIENCE, (1999), vol. 285, page 110-
DESCRIPTION- WILCOX ET AL., TETRAHEDRON LETT., (1986), vol. 27, page 1011-
DESCRIPTION- X-Q TANG ET AL., J. ORG. CHEM., (1999), vol. 64, pages 747 - 754-
DESCRIPTION- Y. MURAI ET AL., HETEROCYCLES, (1992), vol. 33, pages 391 - 404-
DESCRIPTION- K. ISHI ET AL., "Expression of Hepatitis C Virus NS5B Protein: Characterization of Its RNA Polymerase Activity and RNA Binding", HEPATOLOGY, (1999), vol. 29, doi:doi:10.1002/hep.510290448, pages 1227 - 1235, XP002931585
DESCRIPTION- V. LOHMANN ET AL., "Biochemical and Kinetic Analyses of NS5B RNA-Dependent RNA Polymerase of the Hepatitis C Virus", VIROLOGY, (1998), vol. 249, doi:doi:10.1006/viro.1998.9311, pages 108 - 118, XP004445675
DESCRIPTION- H. ROSEN ET AL., "Hepatitis C virus: current understanding and prospects for future therapies", MOLECULAR MEDICINE TODAY, (1999), vol. 5, doi:doi:10.1016/S1357-4310(99)01523-3, pages 393 - 399, XP002284451
DESCRIPTION- R. BARTENSCHLAGER, "Candidate Targets for Hepatitis C Virus-Specific Antiviral Therapy", INTERVIROLOGY, (1997), vol. 40, doi:doi:10.1159/000150570, pages 378 - 393, XP001010333
EXAMINATION- Michael Von Büren ET AL, "Branched oligodeoxynucleotides: Automated synthesis and triple helical hybridization studie", Tetrahedron, (19950701), vol. 51, no. 31, doi:10.1016/0040-4020(95)00452-E, ISSN 0040-4020, pages 8491 - 8506, XP055099254
EXAMINATION- WOLFE M S ET AL, "A Concise Synthesis of 2@?-C-Methylribonucleosides", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL, (19951016), vol. 36, no. 42, doi:10.1016/0040-4039(95)01635-U, ISSN 0040-4039, pages 7611 - 7614, XP004027097
OPPOSITION- GABRIELSEN et al., "In vitro and in vivo antiviral (RNA) evaluation of orotidine 5'-monophosphate decarboxylase inhibitors and analogues including 6-azauridine- 5' -(ethyl methoxyalaninyl)phosphate (a 5'- monophosphate prodrug", Antiviral Chemistry 6t Chemotherapy, (19940000), vol. 5, no. 4, pages 209 - 220, XP000645550-
OPPOSITION- VON BUREN et al., "Branched Oligodeoxynucleotides: Automated Synthesis and Triple Helical Hybridization Studies", Tetrahedron, (19950000), vol. 51, no. 31, doi:10.1016/0040-4020(95)00452-E, pages 8491 - 8506, XP055099254
OPPOSITION- WOLFE et al., "A Concise Synthesis of 2'-C-Methylribonucleosides", Tetrehedron Letters, (19950000), vol. 36, no. 42, doi:10.1016/0040-4039(95)01635-U, pages 7611 - 7614, XP086038414
OPPOSITION- HARRY-O'KURU R E, SMITH J M, WOLFE M S, "A SHORT, FLEXIBLE ROUTE TOWARD 2'-C-BRANCHED RIBONUCLEOSIDES", Journal of Organic Chemistry, Washington, (19970101), vol. 62, no. 6, doi:10.1021/jo961893+, ISSN 0022-3263, pages 1754 - 1759, XP002250483
OPPOSITION- TANG et al., "2'-C Branched Ribonucleosides: Synthesis of the Phosphoramidate Derivatives of 2'-C-j3-Methylcytidine and Their Incorporation into Oligonucleotides", J. Org. Chem., (19990000), vol. 64, doi:10.1021/jo981329u, pages 747 - 754, XP002156891
OPPOSITION- MEIER C, "PRO-NUCLEOTIDES - RECENT ADVANCES IN THE DESIGN OF EFFICIENT TOOLS FOR THE DELIVERY OF BIOLOGICALLY ACTIVE NUCLEOSIDE MONOPHOSPHATES", SYNLETT, DE, (19980101), doi:10.1055/s-1998-1637, ISSN 0936-5214, pages 233 - 242, XP000942298
OTHER- VON BÜREN M. ET AL, "BRANCHED OLIGODEOXYNUCLEOTIDES: AUTOMATED SYNTHESIS AND TRIPLE HELICAL HYBRIDIZATION STUDIE", TETRAHEDRON, (199507), vol. 51, no. 31, pages 8491 - 8506, XP055099254
SEARCH- GABRIELSEN B ET AL, "IN VITRO AND IN VIVO ANTIVIRAL (RNA) EVALUATION OF OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE INHIBITORS AND INHIBITORS AND ANALOGUES INCLUDING 6-AZAURIDINE-5'-(ETHYL METHOXYALANINYL) PHOSPHATE (A 5'-MONOPHOSPHATE PRODRUG", ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, BLACKWELL SCIENTIFIC PUBL., LONDON, GB, (19940101), vol. 5, no. 4, ISSN 0956-3202, pages 209 - 220, XP000645550 [X] 6-8 * compound 3 *-
SEARCH- LEFEBVRE I ET AL, "Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19950929), vol. 38, no. 20, doi:10.1021/JM00020A007, ISSN 0022-2623, pages 3941 - 3950, XP002293734 [A] 6 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents